ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Health Minister Dr C. Vijaya Baskar Inaugurates the First-of-its-kind 'BONDS' Centre at SIMS Hospital, Vadapalani

Chennai (Tamil Nadu) [India], Oct 29 (ANI/NewsVoir): SIMS Hospital (SRM Institutes for Medical Science) one of the leading quaternary care super specialty hospital in Chennai, announced today, the launch of BONDS, (BOtulinum ToxiN in Dystonia and Spasticity), a first of its kind centre in Chennai with focused approach to the treatment of movement disorders like Dystonia and Spasticity (also for Stroke Rehabilitation) using Botulinum Toxin injection at its Vadapalani facility in Chennai.

ANI Oct 29, 2020 18:44 IST googleads

Dr C Vijaya Baskar, Minister for Health and Family Welfare, Govt. of Tamil Nadu Inaugurates 'BONDS' Centre of Excellence

Chennai (Tamil Nadu) [India], Oct 29 (ANI/NewsVoir): SIMS Hospital (SRM Institutes for Medical Science) one of the leading quaternary care super specialty hospital in Chennai, announced today, the launch of BONDS, (BOtulinum ToxiN in Dystonia and Spasticity), a first of its kind centre in Chennai with focused approach to the treatment of movement disorders like Dystonia and Spasticity (also for Stroke Rehabilitation) using Botulinum Toxin injection at its Vadapalani facility in Chennai.
Inaugurated by Dr. C Vijaya Baskar- Minister for Health and Family Welfare, Govt. of Tamil Nadu, in the presence of Ravi Pachamuthu - SRM Group, and other dignitaries, the Center of excellence prides of a state-of-the-art facility, complete with a vibrant and skilled team of doctors to handle neurological emergencies in addition to serving chronic patients.
The Center is well equipped to offer wide spectrum of services to treat patients affected by various movement disorders including stroke, dystonia, spasticity and neuromuscular ailments.
"SIMS has always been a proponent of evidence based clinical innovations. 'BONDS' Clinic marks yet another milestone in this journey and I congratulate Dr Meenakshisundarm and his team for setting-up this center of excellence, which I am sure, will bring in a significant relief to the people with movement disorders," said Ravi Pachamoothoo, Chairman, SRM Group, while expressing his delight about the launch.
"With such finest clinical talents and resources available in-house, who are always ready to adopt and embrace the latest and highly advanced medical practices, both, effectively and efficiently, we at SIMS will continue to deliver high rates of successful clinical treatments for our patients," he added.
An equally elated, Dr U. Meenakshisundaram, the Director of the Neurology Department at SIMS Hospital, who is also the present Secretary of the Movement Disorders Society of India and an Executive Committee member of the Indian Academy of Neurology, said, "Clinical research findings have revealed that over last few years the use of Botulinum toxin has shown great results in the treatment of movement disorders and when combined with a proper physiotherapy regimen, people with these conditions recover faster and return to a near-normal life much quickly. Also, administering Botulinum Toxin Injection is a skilled procedure and is done by skilled set of experienced practitioners, complete with progressive monitoring on the patient's improvement."
"The treatment is done as an outpatient procedure and spans between 3 to 6 months duration with minimal side effects caused due to the weakening of muscles, which are mostly reversible depending on the patient's medical condition and their response to the treatment," Dr Meenakshisundaram added.
A case reference of a successful treatment
An Indian student in his 20s developed spastic weakness in his left hand and leg due to an infarct in the brain resulting from sudden pulmonary thromboembolism during a skiing accident in South Korea. He was initially treated at a hospital in Japan; after which he was referred to SIMS Hospital for further management of his spasticity. He was evaluated and injected with Botulinum toxin and two weeks later, he had significant relief from the spasticity, thus substantially reducing his disability.
Botulinum toxin is like the "villain who turned hero". It is produced by the bacteria Clostridium Botulinum. Ingestion of this toxin can lead to the deadly disease called botulism. It basically paralyses muscles (and some secretory activity). Science has made use of this feature and has brought in the concept of "controlled paralysis", wherein only the abnormally excessive unwanted activity is reduced while retaining and supporting meaningful muscle activity.
Although there are many types of toxins produced, only types A and B are used in medical practice (In India, we have only type A available as of now). Neurons or nerve cells communicate with one other and with muscle and other organs through chemicals called neurotransmitters. Botulinum toxin primarily acts by blocking the release of the neurotransmitter acetylcholine.
By this way, it helps in relieving unwanted, excessive muscle contraction. In this way, it has been applied to a wide variety of conditions including for cosmetic purposes. In neurology, it is primarily used in dystonias and spasticity apart from conditions such as chronic migraine, hyperhidrosis (increased sweating) and sialorrhea (increased drooling of saliva).
Dystonias are a group of disorders which cause abnormal posturing or movements of a body part(s) because some muscle groups go into abnormal, asynchronous contraction. They cause significant disability and discomfort to the sufferers and are in general not very responsive to treatment with oral medications. A common type is the task-specific dystonia where it occurs only with specific tasks such as writing (writer's cramps), playing musical instruments (such as Piano, Guitar, Mridangam etc.) playing golf or billiards, or counting currency notes.
Spasticity is abnormal stiffness that happens in diseases of the brain and/or spinal cord. The stiffness can be pronounced and can cause considerable difficulty in activities of daily living. It can happen in children due to cerebral palsy and other disorders. A common setting is post-stroke spasticity wherein the paralysed limb(s) become stiff over time and cause impediments to further recovery.
SIMS Hospital (SRM Institutes for Medical Science) is one of the leading quaternary care super speciality hospital in Chennai. This 345-bed hospital offers comprehensive healthcare experience across a wide range of specialities, including multi-organ transplant services. The hospital houses 15 modular OTs, 3 state-of-the-art Cath labs (including 1 Bi-plane Cath lab), advanced ICUs with Hepa filters and innovative medical technologies, all under one roof.
With the finest combination of experience, expertise, cutting-edge technology and well-coordinated multi-speciality Quaternary care facilities and patient-centric team-work, SIMS Hospital Chennai is committed to deliver services of international standards.
SIMS Hospital offers holistic health care that includes prevention, prophylactic treatment and care, rehabilitation and lifestyle health education and guidance to patients, their families and clients. At SIMS, every step is aimed at ensuring excellence in patient care.
This story is provided by NewsVoir. ANI will not be responsible in any way for the content of this article. (ANI/NewsVoir)

Get the App

What to Read Next

Business

India Emerging as Stable Investment Anchor in Turbulent Global

India Emerging as Stable Investment Anchor in Turbulent Global

Mumbai (Maharashtra) [India], March 12: As military conflict in West Asia disrupts energy supplies through the Strait of Hormuz and global liquidity tightens, leading investors, policymakers and capital markets leaders gathered at IGF Mumbai 2026: Catalysing Capital to assess India's position in an increasingly fragmented global economy.

Read More
Business

Sarbabharatiya Sangeet O Sanskriti Parishad Convenes 48th Annual

Sarbabharatiya Sangeet O Sanskriti Parishad Convenes 48th Annual

Kolkata (West Bengal) [India], March 12: Sarbabharatiya Sangeet O Sanskriti Parishad officially commenced its 48th Annual Convocation yesterday, March 11, at the historic Mahajati Sadan, Kolkata. The three-day event, running from March 11 to 13, celebrates the institution's legacy of cultural service and its mission to bridge traditional heritage with a modernized future.

Read More
Business

Nandita Desai Unveils a Unique Painting Exhibition on Vintage

Nandita Desai Unveils a Unique Painting Exhibition on Vintage

New Delhi [India], March 12: There is something quietly powerful about a window... It neither confines nor escapes. It simply allows us to look, to pause, to breathe between inner and outer worlds. In The Painted Window, multi-award-winning contemporary artist Nandita Desai turns this everyday architectural element into the soul of her fifth solo exhibition, transforming vintage and handcrafted windows into luminous works of art. Running from 16th to 21st March 2026 at the Kamalnayan Bajaj Art Gallery, Nariman Point, Mumbai, the exhibition brings together 50 artworks - windows that look outward at the world, and inward at memory and quiet reflection.

Read More
Business

PM Narendra Modi To Headline NXT Summit 2026 Today

PM Narendra Modi To Headline NXT Summit 2026 Today

New Delhi [India], March 12: Prime Minister Narendra Modi will headline the NXT Summit 2026 in New Delhi today, March 12. PM Modi will inaugurate the Bharat Progress Report and deliver the chief guest's address at the three-day global leadership forum.

Read More
Business

With India’s Fasteners Market Projected at USD 17 Billion by 2034

With India’s Fasteners Market Projected at USD 17 Billion by 2034

New Delhi [India], March 12: The Indian fasteners market continues to demonstrate strong momentum, having reached USD 11.2 billion in 2025 and is projected by the IMARC Group to surge to USD 17.0 billion by 2034, reflecting a robust CAGR of 4.67% during 2026-2034. This dynamic growth is fueled by the expansion of the automotive, construction, and industrial sectors, as well as increasing demand for high-performance, lightweight fasteners, and strategic government initiatives such as "Make in India." In this thriving context and to boost domestic manufacturing, Messe Stuttgart India has launched FASTNEX 2027 with its highly anticipated Signature Edition, set to take place from 8th to 10th February 2027 at the Bombay Exhibition Centre, Mumbai. The event stands as a crucial platform for industry professionals to showcase innovative products, access market intelligence, foster collaborations, and expand their business networks, ultimately contributing to the overall advancement of India's manufacturing sector.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.